Home » Stocks » ANTH

Anthera Pharmaceuticals, Inc. (ANTH)

Stock Price: $0.116 USD -0.055 (-32.06%)
Updated Feb 24, 2021 4:00 PM EST - Market closed
Market Cap 399,773
Revenue (ttm) n/a
Net Income (ttm) -24.93M
Shares Out 22.17M
EPS (ttm) -1.76
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day February 24
Last Price $0.116
Previous Close $0.170
Change ($) -0.055
Change (%) -32.06%
Day's Open 0.170
Day's Range 0.101 - 0.170
Day's Volume 972,188
52-Week Range -

News

There are no news available yet.

About ANTH

Anthera Pharmaceuticals, a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreem... [Read more...]

Industry
Biotechnology
IPO Date
Mar 1, 2010
CEO
J. Craig Thompson
Employees
21
Stock Exchange
OTCMKTS
Ticker Symbol
ANTH
Full Company Profile

Financial Performance

Financial Statements